Today: 5 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Coupang stock sinks nearly 10% as fresh data leak, U.S. subpoena rattle CPNG shares

Coupang stock sinks nearly 10% as fresh data leak, U.S. subpoena rattle CPNG shares

Coupang shares fell 9.7% to $17.57 Thursday after the company disclosed data from another 165,000 users was exposed in a November breach. The U.S. House Judiciary Committee subpoenaed Coupang as part of a probe into alleged discrimination against American firms. Bernstein began coverage with an Underperform rating. Coupang said no payment or login data was compromised.
5 February 2026
··
IonQ stock tumbles again as short-seller report hangs over quantum trade

IonQ stock tumbles again as short-seller report hangs over quantum trade

IonQ shares fell about 11% to $31.49 Thursday after Wolfpack Research released a short report questioning the company’s reliance on U.S. defense funding. IonQ denied the claims, calling them “false, misleading, and unsubstantiated.” Other quantum computing stocks, including Rigetti and D-Wave, also dropped sharply. Investors await IonQ’s February 25 earnings for further details.
5 February 2026
···
Natural gas price today: Henry Hub steadies after huge EIA draw as Cheniere stock slips

Natural gas price today: Henry Hub steadies after huge EIA draw as Cheniere stock slips

U.S. natural gas futures rose about 1% to $3.51/mmBtu Thursday after the EIA reported a 360 bcf storage withdrawal, below analyst forecasts. Storage stood at 2,463 bcf, 27 bcf under the five-year average. Cheniere Energy filed to expand its Corpus Christi LNG facility, while gas-linked stocks traded mixed in afternoon action. March contract volatility hit new highs following sharp swings last week.
5 February 2026
··
C3.ai AI stock price sinks again as insider sale and software rout keep pressure on NYSE:AI

C3.ai AI stock price sinks again as insider sale and software rout keep pressure on NYSE:AI

C3.ai shares fell 7% to $10.33 Thursday after a regulatory filing showed Executive Chairman Thomas Siebel sold 27,605 shares at $10.81 each. The broader S&P 500 software and services index dropped 2.8%, erasing over $950 billion in value since January 28. Investors are watching for signals from C3.ai’s March conference amid sector-wide concerns over AI’s impact.
5 February 2026
··
XRP price tumbles nearly 19% as bitcoin slide and Fed chair pick weigh on crypto

XRP price tumbles nearly 19% as bitcoin slide and Fed chair pick weigh on crypto

XRP plunged 19% to $1.22 in 24 hours as crypto markets sold off, with $52 million in XRP futures liquidated, CoinGlass reported. Bitcoin fell to $66,675, its lowest since October 2024, while ether dropped over 7%. Senate Democrats urged a delay in hearings for Fed chair nominee Kevin Warsh amid ongoing investigations. Ripple said it integrated Hyperliquid into its institutional brokerage service.
5 February 2026
···
Alphabet stock (GOOGL) slides as Google’s AI capex bill grows — what Wall Street watches next

Alphabet stock (GOOGL) slides as Google’s AI capex bill grows — what Wall Street watches next

Alphabet shares fell 2.4% Thursday, closing at $324.95 after the company announced 2026 capital spending of up to $185 billion, nearly double its 2025 budget. The stock earlier dropped as much as 8%. Alphabet reported Q4 revenue of $113.8 billion and net income of $34.5 billion. Investors are watching for Amazon’s earnings after the bell.
5 February 2026
···
Silver price dives about 15% as selloff resumes — what traders watch next for XAG/USD

Silver price dives about 15% as selloff resumes — what traders watch next for XAG/USD

Spot silver plunged nearly 15% to around $75 an ounce Thursday, after swinging between $72 and $90 in volatile trading. The dollar hit a two-week high and U.S. stocks fell, as investors faced margin calls and trimmed leveraged positions. Silver funds dropped sharply, with SLV down almost 12%. The U.S. payrolls report was postponed to Feb. 11 after a brief government shutdown.
5 February 2026
··
Dow Jones today: Index slides about 1% as Alphabet capex plan stirs fresh AI jitters

Dow Jones today: Index slides about 1% as Alphabet capex plan stirs fresh AI jitters

The Dow Jones fell 502.57 points, or 1.02%, to 48,998.73 Thursday as tech stocks slid after Alphabet announced plans to nearly double capital spending for AI. Qualcomm shares dropped on weak guidance, while Amazon slipped ahead of earnings. Weekly jobless claims rose to 231,000 and U.S. layoffs hit a 17-year January high. The CBOE volatility index reached its highest level in over two months.
5 February 2026
········
Bitcoin price sinks more than 10% below $70,000 as Warsh Fed pick and ETF exits spook crypto

Bitcoin price sinks more than 10% below $70,000 as Warsh Fed pick and ETF exits spook crypto

Bitcoin plunged 10.5% to $65,713 on Thursday, falling below $70,000 for the first time since late 2024. The drop followed heavy outflows from U.S. spot bitcoin ETFs and concerns over tighter Federal Reserve policy after Kevin Warsh was named Trump’s Fed chair pick. Crypto-linked stocks, including Strategy, also slumped. Ether fell 10% to $1,926.
5 February 2026
···
Exxon Mobil (XOM) stock slips as oil drops — what to watch before Friday U.S.-Iran talks

Exxon Mobil (XOM) stock slips as oil drops — what to watch before Friday U.S.-Iran talks

Exxon Mobil shares fell 1.5% to $145.38 as crude prices dropped over 3% ahead of U.S.-Iran talks set for Friday in Oman. The company finalized a $2.32 billion deal for the FPSO One Guyana vessel, with SBM Offshore operating it through 2035. Vice president Darrin L. Talley sold 5,000 shares on Feb. 2 at about $139.75 each, according to a regulatory filing.
5 February 2026
···
Bristol Myers Squibb stock rises on 2026 guidance as Eliquis price cut comes into view

Bristol Myers Squibb stock rises on 2026 guidance as Eliquis price cut comes into view

Bristol Myers Squibb shares rose 1.7% to $58.58 by midday Thursday, bucking a broader market decline, after the company issued a 2026 outlook projecting up to $47.5 billion in revenue. Quarterly revenue increased 1% to $12.5 billion, with growth portfolio sales up 16% and legacy drugs down 15%. The company expects Eliquis sales to rise despite U.S. price negotiations, but warned of a potential $2 billion drop in 2027 when European patents expire.
5 February 2026
··
1 … 97 98 99 100 101 … 688
Go toTop